← Top stories
Funding and debt● Neutral for Sun Pharma
Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
The brief
- Sun Pharma plans to raise about ₹10,000 crore through rupee-denominated bonds
- The sale would partly refinance a bridge loan used for its Organon acquisition
- Sun Pharma investors will track refinancing costs and the company’s debt following its Organon acquisition